S 1930
Small Biotech Innovation Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 9:08 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Small Biotech Innovation Act, amends the Social Security Act to create an exception for small biotechnology manufacturers from Medicare’s drug price negotiation program. Specifically, it exempts certain drugs – defined as ‘qualifying single source drugs’ – produced by manufacturers meeting specific criteria, including a limited number of drugs and significant investment in research and development. The bill establishes a process for manufacturers to apply for this exception, ensuring transparency and providing a mechanism for appeal if a determination is made that they don’t meet the criteria.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.